IBI3034
/ Innovent Biologics
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 22, 2026
IBI3034 Study in Healthy Adults and Patients With Primary IgA Nephropathy
(clinicaltrials.gov)
- P1 | N=100 | Not yet recruiting | Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
New P1 trial • Glomerulonephritis • IgA Nephropathy • Renal Disease
1 to 1
Of
1
Go to page
1